Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016

BACKGROUND: The Centers for Disease Control and Prevention (CDC) currently recommends dual therapy with ceftriaxone and azithromycin for gonorrhea to ensure effective treatment and slow emergence of antimicrobial resistance. Since 2013, the prevalence of reduced azithromycin susceptibility increased...

詳細記述

保存先:
書誌詳細
出版年:Clin Infect Dis
主要な著者: Katz, Alan R., Komeya, Alan Y., Kirkcaldy, Robert D., Whelen, A. Christian, Soge, Olusegun O., Papp, John R., Kersh, Ellen N., Wasserman, Glenn M., O’Connor, Norman P., O’Brien, Pamela S., Sato, Douglas T., Maningas, Eloisa V., Kunimoto, Gail Y., Tomas, Juval E.
フォーマット: Artigo
言語:Inglês
出版事項: 2017
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6748320/
https://ncbi.nlm.nih.gov/pubmed/28549097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix485
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料